4.6 Article

Disparity of access to kidney transplantation by Indigenous and non-Indigenous Australians

期刊

MEDICAL JOURNAL OF AUSTRALIA
卷 209, 期 6, 页码 261-266

出版社

AUSTRALASIAN MED PUBL CO LTD
DOI: 10.5694/mja18.00304

关键词

-

向作者/读者索取更多资源

Objective: To compare the likelihood of Indigenous and non-Indigenous Australians being placed on the waiting list for transplantation of a kidney from a deceased donor; to compare the subsequent likelihood of transplantation. Design, setting and participants: Observational cohort study; analysis of data from the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry for patients aged 18-60 years at the start of renal replacement therapy, who commenced renal replacement therapy in Australia between 28 June 2006 and 31 December 2016. Main outcome measures: Time to wait-listing; time to kidney transplantation after wait-listing. Results: 10 839 patients met the inclusion criteria, of whom 2039 (19%) were Indigenous Australians; 217 Indigenous and 3829 non-Indigenous patients were active on the waiting list at least once during the study period. The hazard ratio (HR) for wait-listing (Indigenous v non-Indigenous patients, adjusted for patient- and disease-related factors) in the first year of renal replacement therapy varied with age and remoteness (range, 0.11 [95% CI, 0.07-0.15] to 0.36 [95% CI, 0.16-0.56]); in subsequent years the adjusted HR was 0.90 (95% CI, 0.50-1.6). The adjusted HR for transplantation during the first year of wait-listing did not differ significantly from 1.0; for subsequent years of wait-listing, however, the adjusted HR was 0.40 (95% CI, 0.29-0.55). Conclusion: Disparities between Indigenous and non-Indigenous patients with end-stage kidney disease in access to kidney transplantation are not explained by patient- or disease-related factors. Changes in policy and practice are needed to reduce these differences.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

Risk factors for incident kidney disease in older adults: an Australian prospective population-based study

Amy Kang, Louisa Sukkar, Carinna Hockham, Min Jun, Tamara Young, Anish Scaria, Celine Foote, Brendon L. Neuen, Alan Cass, Carol Pollock, Elizabeth Comino, Thomas Lung, Roberto Pecoits-Filho, Kris Rogers, Meg J. Jardine

Summary: This large population-based study found that multiple factors, including age, residential area, smoking, obesity, diabetes, hypertension, coronary heart disease, depression/anxiety, and cancer, were independently associated with the development of CKD. Migrants were less likely to develop CKD compared to those born in Australia.

INTERNAL MEDICINE JOURNAL (2022)

Article Transplantation

A co-designed integrated kidney and diabetes model of care improves mortality, glycaemic control and self-care

Edward Zimbudzi, Clement Lo, Sanjeeva Ranasinha, Arul Earnest, Helena Teede, Tim Usherwood, Kevan R. Polkinghorne, Gregory Fulcher, Martin Gallagher, Stephen Jan, Alan Cass, Rowan Walker, Grant Russell, Greg Johnson, Peter G. Kerr, Sophia Zoungas

Summary: This study evaluated the impact of a diabetes and kidney disease service on hospitalization, mortality, and clinical outcomes. The results showed that patients who received the intervention had higher hospitalization rates, shorter length of stay, and lower all-cause mortality rates. Additionally, improvements in self-care and glycemic control were observed in the intervention group.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Article Medicine, General & Internal

Retrospective case-control study exploring pretransplant predictors for loss of kidney transplant function or death among indigenous kidney transplant recipients

Namrata Khanal, Paul D. Lawton, Alan Cass, Stephen P. McDonald

INTERNAL MEDICINE JOURNAL (2023)

Article Nutrition & Dietetics

Dietary habits in Australian, New Zealand and Malaysian patients with end stage kidney failure: A pre-specified cross-sectional study of the FAVOURED trial participants

Marguerite Conley, Anne Barden, Andrea K. Viecelli, Ashley B. Irish, Alan Cass, Carmel M. Hawley, David Voss, Elaine M. Pascoe, Katie Lenhoff, Kevan R. Polkinghorne, Lai-Seong Hooi, Loke-Meng Ong, Peta-Anne Paul-Brent, Peter G. Kerr, Trevor A. Mori

Summary: This study investigated the dietary habits of patients with kidney failure in Australia, New Zealand, and Malaysia. The findings showed significant regional variation in the intake of fruits, vegetables, and animal protein, which may be attributed to cultural and economic differences. Further research is needed to identify barriers to meeting recommended dietary intakes in different regions.

JOURNAL OF HUMAN NUTRITION AND DIETETICS (2022)

Article Health Care Sciences & Services

Dialysis attendance patterns and health care utilisation of Aboriginal patients attending dialysis services in urban, rural and remote locations

Gillian Gorham, Kirsten Howard, Joan Cunningham, Paul Damian Lawton, A. M. Shamsir Ahmed, Federica Barzi, Alan Cass

Summary: Aboriginal people in the Northern Territory of Australia, especially those living in remote areas, face a heavy burden of kidney failure. Due to a lack of dialysis services in these remote areas, many Aboriginal people are required to relocate to access treatment. This study explores the relationship between the location of dialysis services, dialysis attendance patterns, and health service utilization among Aboriginal patients in the Northern Territory. The findings suggest that missing dialysis treatments is more common among Aboriginal people attending urban services, resulting in higher rates of hospital admissions and emergency department presentations. On the other hand, those receiving care in rural and remote settings have higher dialysis attendance and lower health service utilization. The study concludes that access to rural and remote models of care can potentially improve dialysis attendance and reduce the need for hospitalization among Aboriginal patients.

BMC HEALTH SERVICES RESEARCH (2022)

Article Medicine, General & Internal

Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy The TESTING Randomized Clinical Trial

Jicheng Lv, Muh Geot Wong, Michelle A. Hladunewich, Vivekanand Jha, Lai Seong Hooi, Helen Monaghan, Minghui Zhao, Sean Barbour, Meg J. Jardine, Heather N. Reich, Daniel Cattran, Richard Glassock, Adeera Levin, David C. Wheeler, Mark Woodward, Laurent Billot, Sandrine Stepien, Kris Rogers, Tak Mao Chan, Zhi-Hong Liu, David W. Johnson, Alan Cass, John Feehally, Jurgen Floege, Giuseppe Remuzzi, Yangfeng Wu, Rajiv Agarwal, Hong Zhang, Vlado Perkovic

Summary: This international multicenter randomized clinical trial found that oral methylprednisolone significantly reduced the risk of kidney function decline, kidney failure, or death due to kidney disease in patients with IgA nephropathy at high risk of progression. However, it also increased the incidence of serious adverse events.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Transplantation

Electronic alerts and a care bundle for acute kidney injury-an Australian cohort study

Sradha Kotwal, Sanjeeva Herath, Jonathan Erlich, Sally Boardman, Jennifer Qian, Paul Lawton, Craig Campbell, Andrew Whatnall, Su Teo, A. Rita Horvath, Zoltan H. Endre

Summary: This study demonstrates the potential benefits of early recognition of hospital-acquired acute kidney injury (AKI) in improving patient management and outcomes. Implementation of an intervention bundle may reduce length of stay and improve documentation of AKI and other management measures.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Medicine, General & Internal

Multifaceted intervention to reduce haemodialysis catheter related bloodstream infections: REDUCCTION stepped wedge, cluster randomised trial

Sradha Kotwal, Alan Cass, Sarah Coggan, Nicholas A. Gray, Stephen Jan, Stephen McDonald, Kevan R. Polkinghorne, Kris Rogers, Girish Talaulikar, Gian Luca Di Tanna, Martin Gallagher

Summary: This study indicates that implementing multifaceted interventions did not reduce the rate of CRBSI among patients requiring hemodialysis catheters. Therefore, multifaceted interventions to prevent CRBSI may not be effective in clinical practice settings.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Pharmacology & Pharmacy

Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial

Amy Legg, Niamh Meagher, Sandra A. Johnson, Matthew A. Roberts, Alan Cass, Marc H. Scheetz, Jane Davies, Jason A. Roberts, Joshua S. Davis, Steven Y. C. Tong

Summary: The clinical risk factors for nephrotoxicity in Staphylococcus aureus bacteraemia are still unclear. In a clinical trial comparing standard therapy to combination therapy, it was found that the combination therapy group had a significantly higher incidence of acute kidney injury.

CLINICAL DRUG INVESTIGATION (2023)

Review Urology & Nephrology

Comparing survival in patients with chronic kidney disease across three countries - Results from the study of heart and renal protection-extended review

Benjamin Talbot, Alan Cass, Robert Walker, Lai Hooi, Meg Jardine, Min Jun, Kris Rogers, Louisa Sukkar, Brendan Smyth, Martin Gallagher

Summary: This study examined whether there were differences in survival and causes of death among participants from Australia, Malaysia, and New Zealand in the extended follow-up of the SHARP study. It was found that participants from Malaysia and New Zealand had a higher risk of death compared to participants from Australia.

NEPHROLOGY (2023)

Article Urology & Nephrology

Development and validation of algorithms to identify patients with chronic kidney disease and related chronic diseases across the Northern Territory, Australia

Winnie Chen, Asanga Abeyaratne, Gillian Gorham, Pratish George, Vijay Karepalli, Dan Tran, Christopher Brock, Alan Cass

Summary: This study develops and validates algorithms to identify chronic kidney disease (CKD) and related chronic diseases. The algorithms showed high diagnostic accuracy compared to traditional administrative codes, providing new opportunities for early detection, monitoring, and epidemiological research in kidney disease.

BMC NEPHROLOGY (2022)

Correction Pharmacology & Pharmacy

Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial (Oct, 10.1007/s40261-022-01204-z, 2022)

Amy Legg, Niamh Meagher, Sandra A. Johnson, Matthew A. Roberts, Alan Cass, Marc H. Scheetz, Jane Davies, Jason A. Roberts, Joshua S. Davis, Steven Y. C. Tong

CLINICAL DRUG INVESTIGATION (2023)

Article Endocrinology & Metabolism

Risk of kidney disease following a pregnancy complicated by diabetes: a longitudinal, population-based data-linkage study among Aboriginal women in the Northern Territory, Australia

Matthew J. L. Hare, Louise J. Maple-Brown, Jonathan E. Shaw, Jacqueline A. Boyle, Paul D. Lawton, Elizabeth L. M. Barr, Steven Guthridge, Vanya Webster, Denella Hampton, Gurmeet Singh, Roland F. Dyck, Federica Barzi

Summary: This study aimed to investigate the risk of developing chronic kidney disease (CKD) or end-stage kidney disease (ESKD) following a pregnancy complicated by gestational diabetes mellitus (GDM) or pre-existing diabetes among Aboriginal women in the Northern Territory (NT), Australia. The findings showed that Aboriginal women with GDM or pre-existing diabetes during pregnancy are at high risk of developing CKD and ESKD.

DIABETOLOGIA (2023)

暂无数据